Aristippos Gennadios Catalent, Inc. (CTLT) insider trading activity

Aristippos Gennadios is Group Pres. Pharma & Consumer of Catalent, Inc.. Currently has a direct ownership of 0 shares of CTLT, which is worth approximately $0. The most recent transaction as insider was on Dec 18, 2024, when has been sold 135,286 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Aristippos Gennadios Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 18 2024	SELL Sale (or disposition) back to the issuer	-	135,286 Reduced 100.0%	0 Common Stock
Dec 18 2024	BUY Grant, award, or other acquisition	-	21,562 Added 50.0%	21,562 Common Stock
Aug 02 2024	SELL Open market or private sale	$69,613 $59.55 p/Share	1,169 Reduced 1.02%	113,724 Common Stock
Jul 29 2024	SELL Open market or private sale	$20,486 $58.7 p/Share	349 Reduced 0.3%	114,893 Common Stock
Jul 26 2024	BUY Grant, award, or other acquisition	-	18,746 Added 13.99%	115,242 Common Stock
Dec 08 2023	SELL Payment of exercise price or tax liability	$13,645 $37.18 p/Share	367 Reduced 0.38%	96,496 Common Stock
Dec 08 2023	BUY Grant, award, or other acquisition	-	1,505 Added 1.53%	96,863 Common Stock
Aug 24 2023	SELL Open market or private sale	$17,618 $44.49 p/Share	396 Reduced 0.41%	96,552 Common Stock
Aug 23 2023	BUY Grant, award, or other acquisition	-	1,590 Added 1.61%	96,948 Common Stock
Aug 01 2023	SELL Open market or private sale	$13,271 $47.23 p/Share	281 Reduced 0.32%	86,488 Common Stock
Aug 01 2023	BUY Grant, award, or other acquisition	-	8,870 Added 8.51%	95,358 Common Stock
Aug 25 2022	SELL Open market or private sale	$169,501 $103.04 p/Share	1,645 Reduced 1.86%	86,769 Common Stock
Aug 24 2022	BUY Grant, award, or other acquisition	-	6,771 Added 7.11%	88,414 Common Stock
Jul 26 2022	SELL Open market or private sale	$43,081 $106.9 p/Share	403 Reduced 0.5%	79,784 Common Stock
Jul 26 2022	BUY Grant, award, or other acquisition	-	1,859 Added 2.23%	81,643 Common Stock
Jul 01 2022	BUY Grant, award, or other acquisition	$2,000,097 $107.02 p/Share	18,689 Added 18.9%	80,187 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	4,017 Added 6.13%	61,498 Common Stock
Aug 27 2021	SELL Open market or private sale	$295,734 $130.74 p/Share	2,262 Reduced 3.79%	57,481 Common Stock
Aug 26 2021	BUY Grant, award, or other acquisition	-	8,008 Added 11.82%	59,743 Common Stock
Jul 26 2021	SELL Open market or private sale	$52,568 $113.05 p/Share	465 Reduced 0.91%	50,850 Common Stock
Jul 26 2021	BUY Grant, award, or other acquisition	-	885 Added 1.68%	51,735 Common Stock
Jan 04 2021	SELL Open market or private sale	$11,486 $104.42 p/Share	110 Reduced 0.21%	51,315 Common Stock
Dec 21 2020	SELL Open market or private sale	$1,405,547 $102.88 p/Share	13,662 Reduced 20.99%	51,425 Common Stock
Dec 21 2020	BUY Exercise of conversion of derivative security	$413,002 $30.23 p/Share	13,662 Added 18.26%	61,151 Common Stock

Aristippos Gennadios

Group Pres. Pharma & Consumer

Somerset, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTLT shares.

Notify only if

Value

Insider Trading

Get notified when an Catalent, Inc. insider buys or sells CTLT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Catalent, Inc.

Track Activities on CTLT

Account